Background And Objective: Single nucleotide polymorphisms (SNPs) of paraoxonase 1 (PON1) are known to be associated with the pathogenesis of osteoporosis and periodontitis. However, the effects of PON1 on the osteoblastic differentiation of periodontal ligament (PDL) cells are unclear. In this study, we examined the effects of PON1 on the osteoblastic differentiation of PDL cells, and analysed the role of PON1 SNPs on the pathogenesis of aggressive periodontitis (AgP) in the Japanese population.

Material And Methods: Human PDL (HPDL) cells were exposed to the PON1 plasmid and PON1 inhibitor, 2-hydroxyquinoline, and cultured in mineralization medium. Expression of calcification-related genes and calcified nodule formation were assessed by real-time PCR, an alkaline phosphatase (ALPase) activity assay and Alizarin red staining. Sanger sequencing was performed to evaluate whether PON1 SNPs are associated with the pathogenesis of AgP in Japanese people.

Results: During osteoblastic differentiation of HPDL cells, expression of PON1 mRNA increased in a time-dependent manner. PON1 stimulated an increase in expression of mRNA for calcification-related genes, as well as ALPase activity. In contrast, 2-hydroxyquinoline clearly inhibited the expression of calcification-related genes, ALPase activity and calcified nodule formation in HPDL cells. Moreover, there was a statistically significant difference in the minor allele frequency of PON1 SNP rs854560 between the Japanese control database and patients with AgP in the Japanese population (P = .0190).

Conclusion: PON1 induced cytodifferentiation and mineralization of HPDL cells, and PON1 SNP rs854560 may be associated with the pathogenesis of AgP in the Japanese population.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jre.12507DOI Listing

Publication Analysis

Top Keywords

agp japanese
16
hpdl cells
16
pon1
12
associated pathogenesis
12
osteoblastic differentiation
12
calcification-related genes
12
alpase activity
12
cytodifferentiation mineralization
8
periodontal ligament
8
effects pon1
8

Similar Publications

Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus.

Ann Gen Psychiatry

January 2025

Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.

Background: Seizure threshold increases with age and the frequency of electroconvulsive therapy (ECT). Therefore, therapeutic seizures can be difficult to induce, even at maximum stimulus charge with available ECT devices. Such cases are known as difficult-to-induce-seizures electroconvulsive therapy cases (DECs).

View Article and Find Full Text PDF
Article Synopsis
  • Dual immune checkpoint blockade (ICB) using CTLA4 and PD-(L)1 inhibitors shows improved anti-tumor effectiveness and immune toxicity compared to PD-(L)1 inhibitors alone in advanced non-small-cell lung cancer (NSCLC) patients.
  • Patients with mutations in STK11 and/or KEAP1 genes benefit more from the combination treatment compared to those receiving only PD-(L)1 inhibitors, as shown in the POSEIDON trial.
  • The loss of KEAP1 serves as a strong predictor for the success of dual ICB, as it leads to a more favorable outcome by changing the tumor's immune environment to better engage CD4 and CD8 T cells for anti-tumor activity. *
View Article and Find Full Text PDF

Pathophysiological significance of the p.E31G variant in RAC1 responsible for a neurodevelopmental disorder with microcephaly.

Biochim Biophys Acta Mol Basis Dis

January 2025

Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya, Kasugai 480-0392, Japan; Department of Neurochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Nagoya 466-8550, Japan. Electronic address:

Article Synopsis
  • RAC1 gene encodes a GTPase crucial for actin cytoskeleton and signaling, with mutations linked to a neurodevelopmental disorder causing brain and facial abnormalities.
  • A new variant (p.E31G) was identified in a school-aged boy experiencing developmental delays and microcephaly.
  • Biochemical tests show the p.E31G variant alters RAC1's activity and interacts poorly with PAK1, leading to impaired neuronal differentiation and axonal growth, suggesting it contributes to the patient’s condition.
View Article and Find Full Text PDF

Predictors of continuation for asenapine from real-world data in patients with schizophrenia.

Ann Gen Psychiatry

August 2024

Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan.

Article Synopsis
  • The study investigates factors influencing medication continuation rates for asenapine sublingual tablets in schizophrenia, highlighting the impact of specific antipsychotics and patient characteristics like age and illness duration.
  • Using data from 3,236 cases in Japan, the research identified that higher chlorpromazine doses and longer illness duration (over 25 years) significantly predict better continuation rates for asenapine.
  • The findings suggest that predictors for antipsychotic medication continuation vary by drug, emphasizing the need for a tailored approach in treating schizophrenia based on individual patient factors.
View Article and Find Full Text PDF
Article Synopsis
  • Bipolar disorder is associated with social challenges, increased divorce rates, and family support loss, but there is limited evidence on divorce predictors in real-life scenarios.
  • The study analyzed data from 1071 bipolar disorder outpatients over two years, finding a 2.8% divorce rate, notably higher than the general population in Japan.
  • Factors influencing divorce included younger age and lower BMI for both genders, with men showing younger age and bipolar I as significant, while women had lower BMI and anxiolytic use as key predictors.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!